Sumitomo Chemical India's Profit up by 37%
By Ankur Chandra | Updated at: May 31, 2025 07:30 PM IST
Mumbai, May 28, 2025 – Sumitomo Chemical India Ltd (BSE: 542920, NSE: SUMICHEM) has reported its highest-ever profit after tax (PAT) of ₹506.4 crore for the financial year ending March 31, 2025, reflecting a strong 37% year-on-year (YoY) increase.
Financial Performance Summary
| Particulars | FY25 | FY24 | YoY Change |
|---|---|---|---|
| Revenue from Operations | ₹3,148.5 Cr | ₹2,843.9 Cr | +11% |
| Gross Profit | ₹1,289.6 Cr | ₹1,068.9 Cr | +21% |
| EBITDA | ₹632.1 Cr | ₹474.6 Cr | +33% |
| EBITDA Margin (%) | 20.1% | 16.7% | +339 bps |
| Net Profit (PAT) | ₹506.4 Cr | ₹369.7 Cr | +37% |
| PAT Margin (%) | 16.1% | 13.0% | +308 bps |
| EPS | ₹10.13 | ₹7.40 | – |
In Q4FY25, revenue rose marginally by 1% YoY to ₹679.4 crore. However, net profit declined by 9% YoY to ₹99.8 crore due to pricing-related margin pressure.
Operational Highlights
- Domestic Sales: Made up 78% of the revenue, bolstered by a strong Rabi season and farmer outreach via campaigns like ‘Every Day Farmers’ Day’.
- Exports: Contributed 22%, with gains from geographic diversification reducing pricing impact.
- Product Segments: Insecticides led with 40%, followed by herbicides (22%) and plant growth regulators (11%).
- Speciality Products: Accounted for 29% of revenue, compared to 31% in FY24, highlighting ongoing portfolio innovation.
Strategic Developments
- New Launches: Received regulatory approvals for Excalia Max (fungicide) and Lentigo (herbicide).
- CTPR Manufacturing: Commercial production commenced at Tarapur.
- Subsidiary Progress: Barrix Agro Sciences recorded ~82% revenue growth and turned EBITDA positive, improving from -15% to +16%.
Investments & Liquidity
- Capex: ₹55 crore allocated for a new SCC-innovated plant in Bhavnagar, ₹10 crore for molecule production at Tarapur – both targeted for Q4FY27.
- Working Capital: Improved net working capital days to 89 from 91.
- Cash Reserves: ₹1,668 crore in cash and equivalents.
- Collections: Rose to ₹3,534 crore, up from ₹3,325 crore in FY24.
Management Statement
“FY25 was a breakthrough year,” the management noted, crediting product innovation, digital farmer engagement, and cost control for the record earnings.
FY26 Outlook
The company remains optimistic, supported by early monsoon forecasts and stable commodity pricing. Plans include new product ͏launches, capacity expansion, and greater digital engagement.
Note: No dividend declaration was made for FY25.
Disclaimer: This content is only for informational purpose. It does not make any recommendation to act or invest. Please read the offer documents carefully before investing. Investments are subject to market risks and other risks. There is no guarantee of the actual returns that will be given.
REF: https://nsearchives.nseindia.com/corporate/SUMICHEM_27052025213343_Investor_Presentation.pdf
